141 related articles for article (PubMed ID: 20510315)
1. APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems.
Zhao D; Wang X; Lou G; Peng G; Li J; Zhu H; Chen F; Li S; Liu D; Chen Z; Yang Z
Virus Res; 2010 Aug; 151(2):213-9. PubMed ID: 20510315
[TBL] [Abstract][Full Text] [Related]
2. Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsids.
Hu J; Wang H; Yang L; Wu S; Li Y; Li Y; Li Z
J Glob Antimicrob Resist; 2022 Dec; 31():371-378. PubMed ID: 36396043
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.
Baumert TF; Rösler C; Malim MH; von Weizsäcker F
Hepatology; 2007 Sep; 46(3):682-9. PubMed ID: 17625792
[TBL] [Abstract][Full Text] [Related]
4. Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids.
Nguyen DH; Hu J
J Virol; 2008 Jul; 82(14):6852-61. PubMed ID: 18480459
[TBL] [Abstract][Full Text] [Related]
5. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
6. APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G.
Bouzidi MS; Caval V; Suspène R; Hallez C; Pineau P; Wain-Hobson S; Vartanian JP
J Mol Biol; 2016 Aug; 428(17):3514-28. PubMed ID: 27289067
[TBL] [Abstract][Full Text] [Related]
7. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.
Pery E; Sheehy A; Nebane NM; Brazier AJ; Misra V; Rajendran KS; Buhrlage SJ; Mankowski MK; Rasmussen L; White EL; Ptak RG; Gabuzda D
J Biol Chem; 2015 Apr; 290(16):10504-17. PubMed ID: 25724652
[TBL] [Abstract][Full Text] [Related]
9. The potential role of APOBEC3G in limiting replication of hepatitis B virus.
Mohamadkhani A; Pourdadash A; Tayebi S; Estakhri A; Nazem H; Sotoudeh M; Poustchi H
Arab J Gastroenterol; 2012 Dec; 13(4):170-3. PubMed ID: 23432984
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
[TBL] [Abstract][Full Text] [Related]
11. The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses.
Fehrholz M; Kendl S; Prifert C; Weissbrich B; Lemon K; Rennick L; Duprex PW; Rima BK; Koning FA; Holmes RK; Malim MH; Schneider-Schaulies J
J Gen Virol; 2012 Mar; 93(Pt 3):565-576. PubMed ID: 22170635
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of hepatitis B and duck hepatitis B virus replication by APOBEC3G].
Lei YC; Ma T; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):738-41. PubMed ID: 17064466
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
Nair S; Zlotnick A
J Virol; 2018 May; 92(10):. PubMed ID: 29491156
[TBL] [Abstract][Full Text] [Related]
14. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
Jost S; Turelli P; Mangeat B; Protzer U; Trono D
J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
[TBL] [Abstract][Full Text] [Related]
15. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G.
Nguyen DH; Gummuluru S; Hu J
J Virol; 2007 May; 81(9):4465-72. PubMed ID: 17314171
[TBL] [Abstract][Full Text] [Related]
16. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
Vartanian JP; Henry M; Marchio A; Suspène R; Aynaud MM; Guétard D; Cervantes-Gonzalez M; Battiston C; Mazzaferro V; Pineau P; Dejean A; Wain-Hobson S
PLoS Pathog; 2010 May; 6(5):e1000928. PubMed ID: 20523896
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
[TBL] [Abstract][Full Text] [Related]
18. 7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.
Wang T; Tian C; Zhang W; Luo K; Sarkis PT; Yu L; Liu B; Yu Y; Yu XF
J Virol; 2007 Dec; 81(23):13112-24. PubMed ID: 17881443
[TBL] [Abstract][Full Text] [Related]
19. Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization.
Khan MA; Goila-Gaur R; Kao S; Miyagi E; Walker RC; Strebel K
Retrovirology; 2009 Nov; 6():99. PubMed ID: 19886996
[TBL] [Abstract][Full Text] [Related]
20. Potential roles of placental human beta-defensin-3 and apolipoprotein B mRNA-editing enzyme catalytic polypeptide 3G in prevention of intrauterine transmission of hepatitis B virus.
Bai X; Tian T; Wang P; Yang X; Wang Z; Dong M
J Med Virol; 2015 Mar; 87(3):375-9. PubMed ID: 25196417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
